NovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardCLEVELAND, OH / ACCESSWIRE / March 15, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing

Related Keywords

California ,United States ,Santa Cruz Division ,Dennis Riedl ,Dwain Irvin ,Los Angeles ,Christopher Wheeler ,University Of California ,Securities Exchange Commission ,Department Of Chemistry Biochemistry ,Darrow Associates ,World Orphan Drug Congress ,Novaccess Global Inc View ,World Brain Mapping Foundation ,Vaccine Manufacturing Laboratory ,World Brain Mapping Foundation Annual Congress ,Sinai Medical Center Department Of Neurosurgery ,Society For Brain Mapping ,Securities Exchange ,Our Company ,Novaccess Global Inc ,Stemvax Therapeutics Inc ,Novaccess Lead Scientist ,Receives Prestigious Golden Axon ,Novaccess Global ,Golden Axon Award ,Annual Congress ,Saxon Award ,Brain Mapping ,Stemvax Therapeutics ,Cedars Sinai Medical Center Department ,Operations Director ,Precision Medicine Initiative ,Brain Tumors Department ,Institutional Animal Care ,Use Committee ,Cruz Division ,Biological Sciences ,Access Global ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Relations Contact ,Novaccess ,Lobal ,Christopher ,Heeler ,Head ,Scientist ,Eceives ,Restigious ,Olden ,Exon ,Award ,